Загрузка...
Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
Over the last decade, several rhythm‐versus rate‐control trails in patients with atrial fibrillation (AF) have failed to demonstrate benefit of the rhythm control strategy with respect to mortality and morbidity. This had let to the guideline recommendation that antiarrhythmic drug therapy should be...
Сохранить в:
| Опубликовано в: : | Clin Cardiol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley Periodicals, Inc.
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652313/ https://ncbi.nlm.nih.gov/pubmed/22246949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20959 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|